Edward van Wezel is the Founder and Managing Partner of BioGeneration Ventures, leveraging over 20 years of experience in venture capital and pharma. With a background in chemistry and biochemical process technology, he focuses on early-stage European biotech companies, guiding them from scientific innovation to valuable enterprises across multiple corporate boards.
He was the founding investor and a board member of Acerta Pharma, a company that was successfully acquired by AstraZeneca for $7 billion.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.